Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ddMTX-LDE for LV Remodeling after STEMI
NCT03516903Phase 3Terminated
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2018
- Primary completion
- Dec 2020
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of didodecyl methotrexate lipid core emulsion in ST elevation myocardial infarction (STEMI), sponsored by Universidade de São Paulo. Started Apr 2018; status: terminated.
02
Drugs
didodecyl methotrexate lipid core emulsion
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03516903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516903.